| Dr Abeer Qamar Siddiqi, MD | |
|
22999 Highway 59 N Ste 415, Kingwood, TX 77339-4412 | |
| (281) 358-2314 | |
| (281) 358-2357 |
| Full Name | Dr Abeer Qamar Siddiqi |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 11 Years |
| Location | 22999 Highway 59 N Ste 415, Kingwood, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588059539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | T8351 (Texas) | Secondary |
| 207R00000X | Internal Medicine | T8351 (Texas) | Secondary |
| 208M00000X | Hospitalist | 25MA10565500 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Memorial Hermann Memorial City Hospital | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Houston Ear Nose And Throat Clinic Llp | 3678569860 | 39 |
| Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
Beak and feather disease virus in wild parrot populations has been detected in eight new countries, raising concerns for threatened species.
As the Hawaiian Islands brace for Hurricane Lane, a category 4 hurricane that could potentially impact Hawaii between Thursday and Friday, the diabetes community is rallying to make sure that people living with diabetes that use insulin are taking special precautions.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
The International Serious Adverse Events Consortium (iSAEC) announced today it will collaborate with the University of California, San Diego School of Medicine and UC San Diego Skaggs School of Pharmacy and Pharmaceutical Science to research the genetics of drug induced renal injury (DIRI).
› Verified 6 days ago
| Entity Name | Houston Ear Nose & Throat Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477515617 PECOS PAC ID: 3678569860 Enrollment ID: O20040422001258 |
News Archive
Beak and feather disease virus in wild parrot populations has been detected in eight new countries, raising concerns for threatened species.
As the Hawaiian Islands brace for Hurricane Lane, a category 4 hurricane that could potentially impact Hawaii between Thursday and Friday, the diabetes community is rallying to make sure that people living with diabetes that use insulin are taking special precautions.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
The International Serious Adverse Events Consortium (iSAEC) announced today it will collaborate with the University of California, San Diego School of Medicine and UC San Diego Skaggs School of Pharmacy and Pharmaceutical Science to research the genetics of drug induced renal injury (DIRI).
› Verified 6 days ago
| Entity Name | Memorial Hermann Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
Beak and feather disease virus in wild parrot populations has been detected in eight new countries, raising concerns for threatened species.
As the Hawaiian Islands brace for Hurricane Lane, a category 4 hurricane that could potentially impact Hawaii between Thursday and Friday, the diabetes community is rallying to make sure that people living with diabetes that use insulin are taking special precautions.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
The International Serious Adverse Events Consortium (iSAEC) announced today it will collaborate with the University of California, San Diego School of Medicine and UC San Diego Skaggs School of Pharmacy and Pharmaceutical Science to research the genetics of drug induced renal injury (DIRI).
› Verified 6 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20100317001021 |
News Archive
Beak and feather disease virus in wild parrot populations has been detected in eight new countries, raising concerns for threatened species.
As the Hawaiian Islands brace for Hurricane Lane, a category 4 hurricane that could potentially impact Hawaii between Thursday and Friday, the diabetes community is rallying to make sure that people living with diabetes that use insulin are taking special precautions.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
The International Serious Adverse Events Consortium (iSAEC) announced today it will collaborate with the University of California, San Diego School of Medicine and UC San Diego Skaggs School of Pharmacy and Pharmaceutical Science to research the genetics of drug induced renal injury (DIRI).
› Verified 6 days ago
| Entity Name | Lonestar Hospital Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518237429 PECOS PAC ID: 6709049703 Enrollment ID: O20120530000620 |
News Archive
Beak and feather disease virus in wild parrot populations has been detected in eight new countries, raising concerns for threatened species.
As the Hawaiian Islands brace for Hurricane Lane, a category 4 hurricane that could potentially impact Hawaii between Thursday and Friday, the diabetes community is rallying to make sure that people living with diabetes that use insulin are taking special precautions.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
The International Serious Adverse Events Consortium (iSAEC) announced today it will collaborate with the University of California, San Diego School of Medicine and UC San Diego Skaggs School of Pharmacy and Pharmaceutical Science to research the genetics of drug induced renal injury (DIRI).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Abeer Qamar Siddiqi, MD 14140 Southwest Fwy Ste 20, Sugar Land, TX 77478-3759 Ph: (281) 649-7000 | Dr Abeer Qamar Siddiqi, MD 22999 Highway 59 N Ste 415, Kingwood, TX 77339-4412 Ph: (281) 358-2314 |
News Archive
Beak and feather disease virus in wild parrot populations has been detected in eight new countries, raising concerns for threatened species.
As the Hawaiian Islands brace for Hurricane Lane, a category 4 hurricane that could potentially impact Hawaii between Thursday and Friday, the diabetes community is rallying to make sure that people living with diabetes that use insulin are taking special precautions.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
The International Serious Adverse Events Consortium (iSAEC) announced today it will collaborate with the University of California, San Diego School of Medicine and UC San Diego Skaggs School of Pharmacy and Pharmaceutical Science to research the genetics of drug induced renal injury (DIRI).
› Verified 6 days ago
Rizwan Ali, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 19701 Kingwood Dr Ste 9, Kingwood, TX 77339 Phone: 304-435-7553 |